Brain Garden, the subsidiary of Whole Living of the US, has
reported a further rise in sales for June 2002, the second
consecutive month of improvement after a slow start to the year.
CK Life Sciences International, the Chinese biotech company, is
preparing an initial public offering this week which it is hoped
will raise some HK$2.61 billion (€0.34bn) to finance future growth.
British men are being asked to suffer in the name of science and
drink a litre of beer a day. Researchers from the Institute of Food
Research in Norwich are investigating whether the folate in beer
can help reduce the risk of heart...
A survey of organic fruit and vegetables has shown that they do not
have an appreciably higher nutritional content than equivalent
products grown using conventional techniques.
Rather than worrying about which scientific study to believe when
it comes to choosing a vitamin or mineral supplement, consumers
should concentrate on finding the balance which is right for them.
Hence the term 'mineralibrium',...
Warnings about food supplements which contain ingredients
considered unsuitable for consumption by children have done little
to deter parents in the Indonesian capital Jakarta from
administering them to their children.
Neotame, a new artificial sweetener from NutraSweet, has been given
the go ahead by the US federal government. The sweetener is said to
be 7,000 to 13,000 times sweeter than sugar.
Switzerland's Lonza group has confirmed its commitment to the
construction of a major new production facility in the town of Visp
with the announcement of a SFr100 million (€68.4m) investment in a
biopharmaceuticals manufacturing...
Positive publicity for the fat-fighting supplement Relora has led
to a sharp increase in sales of the product - so much so that
Relora's manufacturer Next Pharmaceuticals is having to work
overtime to meet demand.
Acatris, the Dutch ingredients group, has just published research
which it claims shows that its SoyLife product provides much more
than soy protein and isoflavones.
Taking vitamins to combat the effects of heart disease or cancer is
a waste of time, according to researchers from Oxford University's
Clinical Trial Service.
A new survey, conducted by the UK-based Women's Nutritional
Advisory Service (WNAS), has revealed that increasing numbers of
women are opting for a non-drug approach to the treatment of
menopausal symptoms.
